Marta
Gorraiz Ayala
Publicaciones (19) Publicaciones de Marta Gorraiz Ayala
2024
-
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model
Journal for immunotherapy of cancer, Vol. 12, Núm. 7
2023
2022
-
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy
OncoImmunology, Vol. 11, Núm. 1
-
TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
Cancer Letters, Vol. 528, pp. 45-58
-
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 8
2021
-
Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma
BioMed Research International, Vol. 2021
-
Searching for peptide inhibitors of t regulatory cell activity by targeting specific domains of foxp3 transcription factor
Biomedicines, Vol. 9, Núm. 2, pp. 1-20
2019
-
Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies
Frontiers in Immunology, Vol. 10
-
Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses
Molecular Therapy, Vol. 27, Núm. 11, pp. 1892-1905
-
Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma
Journal of Vascular and Interventional Radiology, Vol. 30, Núm. 7, pp. 1098-1105
2018
-
Immunomodulatory properties of carvone inhalation and its effects on contextual fear memory in mice
Frontiers in Immunology, Vol. 9, Núm. JAN
2017
-
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
Oncotarget, Vol. 8, Núm. 42, pp. 71709-71724
2015
-
Inhibition of FOXP3/NFAT interaction enhances T cell function after TCR stimulation
Journal of Immunology, Vol. 195, Núm. 7, pp. 3180-3189
2013
-
A fusion protein between streptavidin and the endogenous tlr4 ligand EDA targets biotinylated antigens to dendritic cells and induces t cell responses in vivo
BioMed Research International, Vol. 2013
2009
-
Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein
Journal of Hepatology, Vol. 51, Núm. 3, pp. 520-527
2007
-
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo
Journal of Immunology, Vol. 178, Núm. 2, pp. 748-756
2005
-
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus
Vaccine, Vol. 23, Núm. 27, pp. 3493-3499
2003
-
A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage
Hepatology, Vol. 37, Núm. 2, pp. 461-470
2002
-
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus
Vaccine, Vol. 21, Núm. 3-4, pp. 202-210